PositiveID Poised To Carve Out Its Share of the $27.4 Billion Global Polymerase Chain Reaction (PCR) Market in 2015: Analyst Report Issued by Small Cap IR
NEW YORK, March 12, 2015 /PRNewswire/ - PositiveID Corporation (OTCQB: PSID) coordinates with America's homeland defense private/public sectors to develop and produce cutting edge technologies. The Company has been working on the development of microfluidic systems with the ability to detect biological threats remotely, and analyze medical samples onsite.
According to a report released by Research and Markets, the global PCR market is expected to hit $27.4 billion in the coming year fueled by growth prospects of PCR equipments and reagents segment. The Company has announced that it has filed a U.S. Patent for its Firefly DX Real-Time PCR System, positioning the firm to carve out its share of the growing Polymerase Chain Reaction market this year. The Firefly DX will provide real-time, accurate diagnostic results on a portable device allowing remote generation of treatment scenarios. This previously was unable to be completed with existing systems, which would require lab-based equipment and take anywhere from several hours to days to generate results.
With a recent issued revenue guidance of $3-6 million for 2015, we can see the potential growth for this firm in the coming fiscal year.
A report including analysis of PositiveID Corporation's financials and market position can be viewed by clicking the link below. There is no cost obligation to view the analyst brief:
http://bit.ly/--PSID---AnalystReport
Copy and paste to browser may be required.
About Small Cap IR
We make the connection between sophisticated investors and high quality small cap companies. An issuer of reports written by chartered financial analysts (CFA's) who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release please use contact information provided below.
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Contact: [email protected]
SOURCE Small Cap IR
Share this article